Holen Sie sich die Stockscreener-App
0.00
100.00%
-2.67
Psychemedics Corp Aktie (PMD) Neueste Nachrichten
Psychemedics Corp announces qarterly EPS of $0.30 - Reuters
Psychemedics (NASDAQ:PMD) Shares Cross Above 200-Day Moving Average – Here’s Why - Defense World
Psychemedics Corp sees $305,439 in stock purchases by major shareholders - Investing.com
Psychemedics sees significant stock acquisition by investment group By Investing.com - Investing.com Nigeria
Peter Kamin sells $753,663 in Psychemedics Corp stock By Investing.com - Investing.com South Africa
Peter Kamin sells $753,663 in Psychemedics Corp stock - Investing.com India
Psychemedics Corporation (PMD) Completes Stock Repurchase Agreement - Defense World
Psychemedics completes share transactions, funds reverse split - Investing.com
Psychemedics completes share transactions, funds reverse split By Investing.com - Investing.com Canada
Post-Thanksgiving Insider Buying Includes Warren Buffett Pick - 24/7 Wall St.
Psychemedics Corporation's (NASDAQ:PMD) Shares Climb 37% But Its Business Is Yet to Catch Up - Simply Wall St
Psychemedics corp director Peter Kamin purchases $3.31m in stock By Investing.com - Investing.com Nigeria
Psychemedics corp director Peter Kamin purchases $3.31m in stock - Investing.com
Psychemedics Corporation Announces Charles Doucot, to Leave as Executive Vice President, Effective September 15, 2023 - Marketscreener.com
Psychemedics Corporation Announces Board Changes - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com
Psychemedics: Q2 Earnings Snapshot - Marketscreener.com
Psychemedics Corporation Appoints William Norris as Controller of the Company, Effective as of January 1, 2023 - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2021 - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022 - Marketscreener.com
Psychemedics Corporation Declares Cash Dividend for First Quarter Ended March 31, 2022, Payable on June 24, 2022 - Marketscreener.com
Andrew Limbek Joins Psychemedics Corporation as Vice President, Controller - Marketscreener.com
Psychemedics Corporation Appoints Charles M. Doucot as Vice President, Sales and Marketing - Marketscreener.com
Psychemedics Corp. Promotes Sarah Ashby to VP and General Counsel - Marketscreener.com
Psychemedics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 - Marketscreener.com
Psychemedics Corporation Announces Relocation of its Corporate Headquarters to Dallas, Texas - Marketscreener.com
Psychemedics Corporation announced that it expects to receive $3.749998 million in funding from 3K Limited Partnership - Marketscreener.com
Psychemedics: Q3 Earnings Snapshot - Marketscreener.com
Psychemedics Corporation Announces Reverse and Forward Stock Split - Yahoo Finance
Psychemedics Announces 1-for-5,000 Reverse Stock Split, 5,000-for-1 Forward Stock Split - Nasdaq
PMD (Psychemedics) Shares Outstanding (EOP) : 5.90 Mil (As of Sep. 2024) - GuruFocus.com
Psychemedics shareholders approve reverse and forward stock splits - Investing.com
Psychemedics Corporation Reminds Stockholders to Cast Their Votes for Upcoming Annual Meeting of Stockholders - Yahoo Finance
Psychemedics Third Quarter 2024 Earnings: US$0.091 loss per share (vs US$0.36 loss in 3Q 2023) - Yahoo Finance
Psychemedics Q3 Loss Narrows Despite 9% Revenue Drop; Shares Show Mixed Results | PMD Stock News - StockTitan
Psychemedics Corporation Reports Third Quarter 2024 Financial Results - Yahoo Finance
Drug Screening Market Analysis of The Key Players, Growth Status, Business Strategies and Scope with Outlook - The Globe and Mail
Form DEF 14A PSYCHEMEDICS CORP For: Nov 25 - StreetInsider.com
PMD (Psychemedics) Shares Outstanding (EOP) : 5.82 Mil (As of Jun. 2024) - GuruFocus.com
U.S. Employer and Workplace Drug Testing Market Report 2024, Featuring First Advantage, Labcorp, Dragerwerk, Quest Diagnostics, Cordant Health Solutions, HireRight, Omega Laboratories & Psychemedics - Yahoo Finance
Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing - Yahoo Finance
Survey: Mental health professionals largely open to psychedelic treatments – if legal - Green Market Report
474% return in 1 year: PC Jeweller shares hit fresh 52-week high as board to consider stock split - MSN
PC Jeweller's first share split announced: 180 percent multibagger gain in just 3 months - India.com
PC Jeweller Soars 452%! Big News Ahead as Company Plans First-Ever Stock Split on September 30 - Share Price India News
At 52-week high! Multibagger stock PC Jeweller to declare stock split after 452% surge in one year - MSN
This jewellery stock hits 52-week high as board to consider stock split; check details - Upstox
PC Jewellers shares rise 4% on considering stock split in upcoming board meeting - The Economic Times
PC Jeweller shares hit 52-week high ahead of board meeting to consider stock split - Business Upturn
PC Jeweller hits 52-wk high as board to consider stock split on Sept 30 - Business Standard
At 52-week high! Multibagger stock PC Jeweller to declare stock split after 452% surge in one year | Stock Market News - Mint
PC Jeweller shares in news today as board to consider stock split - Business Today
ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World
Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com
Psyence Group offloads PsyLabs stake to spinoff - Green Market Report
PC Jeweller to consider stock split on September 30 - CNBCTV18
Epineuron Announces Health Canada Approval of the PeriPulse™ System for Nerve Regeneration - Business Wire
Popular Foundations Shares Underperform At Market Debut - Knn India
0.17%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):